The Transforming Growth Factor-β Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic Retinopathy

Online-Only Appendix

Files in this Data Supplement:

This Article

  1. Diabetes July 2009 vol. 58 no. 7 1659-1667
  1. AbstractFree
  2. Full Text
  3. Full Text (PDF)
  4. » Online-Only Appendix